Financial Daily from THE HINDU group of publications
Wednesday, Jan 07, 2004
Financial Daily from THE HINDU group of publications Wednesday, Jan 07, 2004 |
||
|
|
||
|
Corporate
-
Mergers & Acquisitions Ranbaxy completes acquisition of RPG (Aventis) Our Bureau
New Delhi , Jan. 6 RANBAXY Laboratories Ltd has completed the acquisition of RPG (Aventis) SA making it the wholly-owned subsidiary of the company. The company will continue to retain the name RPG, to leverage its strong brand equity and visibility in the French generic market. Ranbaxy will also be making additional investments to strengthen and grow the business in the French market. RPG (Aventis) was ranked fifth in the French generic market with sales of 52 million euros with a market share of over 6 per cent. The major therapeutic areas of the company include cardiovasculars, anti-infectives, gastro-intestinals, rheumatoid/non-steroidal anti inflammatory drugs, neurology and analgesics. Commenting on the completion of the acquisition transactions, Dr Brian W. Tempest, Joint Managing Director and CEO designate, Ranbaxy, said, "This completes a further step in the expansion plans we have for Ranbaxy in Europe."
More Stories on : Mergers & Acquisitions | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|